These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30102980)

  • 41. Integrating artificial and human intelligence into tablet production process.
    Gams M; Horvat M; Ožek M; Luštrek M; Gradišek A
    AAPS PharmSciTech; 2014 Dec; 15(6):1447-53. PubMed ID: 24970587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simple assessment of homogeneity in pharmaceutical mixing processes using a near-infrared reflectance probe and control charts.
    Skibsted ET; Boelens HF; Westerhuis JA; Witte DT; Smilde AK
    J Pharm Biomed Anal; 2006 Apr; 41(1):26-35. PubMed ID: 16289623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of chemometric modelling to UV-Vis spectroscopy: development of simultaneous API and critical excipient assay in a liquid solution continuous flow.
    Angheluta A; Guizani S; Saunier J; Rönnback R
    Pharm Dev Technol; 2020 Oct; 25(8):919-929. PubMed ID: 32496145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.
    Martin-Moe S; Lim FJ; Wong RL; Sreedhara A; Sundaram J; Sane SU
    J Pharm Sci; 2011 Aug; 100(8):3031-3043. PubMed ID: 21425164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elucidation and visualization of solid-state transformation and mixing in a pharmaceutical mini hot melt extrusion process using in-line Raman spectroscopy.
    Van Renterghem J; Kumar A; Vervaet C; Remon JP; Nopens I; Vander Heyden Y; De Beer T
    Int J Pharm; 2017 Jan; 517(1-2):119-127. PubMed ID: 27916700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feeding of particle-based materials in continuous solid dosage manufacturing: a material science perspective.
    Hsiao WK; Hörmann TR; Toson P; Paudel A; Ghiotti P; Stauffer F; Bauer F; Lakio S; Behrend O; Maurer R; Holman J; Khinast J
    Drug Discov Today; 2020 Apr; 25(4):800-806. PubMed ID: 31982395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
    Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
    Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact Of Excipient Variability On Drug Product Processing And Performance.
    Peng Soh JL; Liew CV; Sia Heng PW
    Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Review of PAT Strategies in Secondary Solid Oral Dosage Manufacturing of Small Molecules.
    Laske S; Paudel A; Scheibelhofer O;
    J Pharm Sci; 2017 Mar; 106(3):667-712. PubMed ID: 28017464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies.
    Muteki K; Swaminathan V; Sekulic SS; Reid GL
    AAPS PharmSciTech; 2011 Dec; 12(4):1324-34. PubMed ID: 21969245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downstream processing from hot-melt extrusion towards tablets: A quality by design approach.
    Grymonpré W; Bostijn N; Herck SV; Verstraete G; Vanhoorne V; Nuhn L; Rombouts P; Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Oct; 531(1):235-245. PubMed ID: 28823887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
    Van Buskirk GA; Asotra S; Balducci C; Basu P; DiDonato G; Dorantes A; Eickhoff WM; Ghosh T; González MA; Henry T; Howard M; Kamm J; Laurenz S; MacKenzie R; Mannion R; Noonan PK; Ocheltree T; Pai U; Poska RP; Putnam ML; Raghavan RR; Ruegger C; Sánchez E; Shah VP; Shao ZJ; Somma R; Tammara V; Thombre AG; Thompson B; Timko RJ; Upadrashta S; Vaithiyalingam S;
    AAPS PharmSciTech; 2014 Jun; 15(3):665-93. PubMed ID: 24578237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M; Kleinebudde P
    AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downstream processing from melt granulation towards tablets: In-depth analysis of a continuous twin-screw melt granulation process using polymeric binders.
    Grymonpré W; Verstraete G; Vanhoorne V; Remon JP; De Beer T; Vervaet C
    Eur J Pharm Biopharm; 2018 Mar; 124():43-54. PubMed ID: 29248561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.